To view donor-related figures up until 31 December 2021, please refer to the links below.
Germany is a visible actor in global health and a recognised anchor donor of Gavi, the Vaccine Alliance.
Under Chancellor Angela Merkel, Germany made global health a priority during both its G7 and G20 presidencies in 2015 (including hosting Gavi’s 2015 replenishment conference in Berlin) and 2017 respectively. In 2018, Germany partnered with Ghana and Norway to establish the “Global Action Plan for Healthy Lives and Well-Being for All (GAP),” bringing together Gavi and 12 other multilateral agencies to accelerate progress towards the health-related Sustainable Development Goals (SDGs). In October 2020, Germany launched a new government-wide global health strategy for 2020-2030, titled “Responsibility – Innovation – Partnership:Shaping Global Health Together,” to serve as the strategic basis for Germany’s engagement in global health.
As a Gavi donor since 2006, Germany contributes to Gavi through direct contributions via both the Federal Ministry for Economic Cooperation and Development (BMZ) and the KfW Development Bank. The 2013 Vaccine Summit in Abu Dhabi marked Germany’s first multi-year commitment to Gavi by a pledge of EUR 90 million over 2013-2015. As patron of Gavi’s replenishment conference in Berlin in January 2015, Chancellor Merkel pledged EUR 600 million for Gavi over the 2016–2020 strategic period – an impressive milestone in Germany’s history of support for the Vaccine Alliance.
In January 2020, as Gavi met in Davos to celebrate its 20th anniversary, Chancellor Merkel was the first world leader to pledge for Gavi’s 2021-2025 strategic period, announcing Germany’s commitment of another EUR 600 million for the five years.
In September 2020, Germany confirmed a commitment of EUR 100 million towards the Gavi COVAX Advance Market Commitment (COVAX AMC), followed by a EUR 980 million pledge to COVAX in February 2021, which placed Germany firmly among Gavi’s top donors.
In addition, Germany has committed to supply at least 70 million doses of COVID-19 vaccines, mainly to developing countries and primarily via COVAX.
Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five-year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Direct Contributions (including Matching Fund)
Received contributions: non-US$ contributions for 2000-2020 and Q1-Q2 2021 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014-2020 and Q1-Q2 2021 where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions (for pledges made prior to the June 2020 donor pledging conference): non-US$ Direct Contribution and Matching Fund pledges for Q3-Q4 2021 and years 2022 and beyond are expressed in US$ equivalents using the applicable forecast rates from Bloomberg as at 30 June 2021 or using the rates applicable to any hedge agreement in place.
Future contributions (for pledges at the June 2020 donor pledging conference): non-US$ Direct Contribution and Matching Fund pledges for Q3-Q4 2021 and for years 2022 and beyond are expressed in US$ equivalents using the spot rates from Bloomberg as at 30 June 2021 or using the rates applicable to any hedge agreement in place.
Received contributions: non-US$ contributions for 2000-2020 and for Q1-Q2 2021 are expressed in US$ equivalents as confirmed by the IBRD (World Bank)
'Future contributions: non-US$ contributions for Q3-Q4 2021 and for years 2021 and beyond are expressed in US$ equivalents as follows:
For signed contribution agreements: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements.
For contribution agreements not yet signed: contributions are expressed in US$ equivalents using the applicable spot rates from Bloomberg as at 30 June 2021
Due to IFFIm’s nature as a frontloading vehicle, yearly contributions paid into IFFIm can differ significantly from yearly proceeds transferred to Gavi.
'While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the amount due by the donor in the event that a Gavi-supported programme country is in protracted arrears with the International Monetary Fund. As of 29 June 2021, there is no longer any reduction applied, as all countries from the reference portfolio have cleared their arrears with the IMF.